The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterizing outcomes of ERBB2-amplified biliary tract cancer.
 
Daniel Aaron Fox
No Relationships to Disclose
 
Jaime Haro-Silerio
No Relationships to Disclose
 
Deepak Bhamidipati
No Relationships to Disclose
 
Funda Meric-Bernstam
Employment - MD Anderson Cancer Center
Consulting or Advisory Role - Abbvie; Apeiron Biologics; AstraZeneca; Biovica; Black Diamond Therapeutics; Calibr; EcoR1 Capital; Eisai; Infinity Pharmaceuticals; Karyopharm Therapeutics; LegoChem Biosciences; Lengo Therapeutics; Loxo; Menarini Group; OnCusp Therapeutics; PACT Pharmaceuticals; Protai; Roche; Seagen; Tallac Therapeutics; Theratechnologies; Zymeworks
Research Funding - Abbvie (Inst); Aileron Therapeutics (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Calithera Biosciences (Inst); Curis (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Debiopharm Group (Inst); eFFECTOR Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Guardant Health (Inst); Jounce Therapeutics (Inst); Klus Pharma (Inst); Novartis (Inst); Pfizer (Inst); PUMA Biotechnology (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Cholangiocarcinoma Foundation; ESMO; European Organisation for Research and Treatment of Cancer (EORTC)
 
Shubham Pant
Consulting or Advisory Role - AskGene Pharma; Boehringer Ingelheim; Ipsen; Janssen; Novartis; Zymeworks
Research Funding - 4D Pharma (Inst); Amal Therapeutics (Inst); Arcus Biosciences (Inst); Astellas Pharma (Inst); bionte (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Elicio Therapeutics (Inst); Immuneering (Inst); ImmunoMET (Inst); Ipsen (Inst); Janssen (Inst); Lilly (Inst); Mirati Therapeutics (Inst); NGM Biopharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Purple Biotech (Inst); Rgenix (Inst); Xencor (Inst); Zymeworks (Inst)
 
Jeffrey S. Ross
Employment - Foundation Medicine
Leadership - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
Consulting or Advisory Role - Celsius Therapeutics; Tango Therapeutics
Research Funding - Foundation Medicine
 
Zishuo Ian Hu
No Relationships to Disclose
 
Eugene Jon Koay
Honoraria - Apollo
Consulting or Advisory Role - Augmenix; RenovoRx
Speakers' Bureau - Oncology Information Group
Research Funding - Elekta; GE Healthcare; Philips Healthcare
Patents, Royalties, Other Intellectual Property - Provisional patent on 3D printed oral stents for radiation treatments of head and neck cancer; Royalties from Taylor and Francis LLC for my co-authored book: An introduction to physical oncology
 
Ethan B. Ludmir
Employment - Alaunos Therapeutics (I)
 
Hop Sanderson Tran Cao
No Relationships to Disclose
 
Ching-Wei D. Tzeng
Honoraria - PanTher Therapeutics
Research Funding - Sirtex Medical (Inst)
 
Yun Shin Chun
No Relationships to Disclose
 
Jean-Nicolas Vauthey
No Relationships to Disclose
 
Timothy E. Newhook
No Relationships to Disclose
 
Zeyad Metwalli
No Relationships to Disclose
 
Peiman Habibollahi
No Relationships to Disclose
 
Veronica L. Cox
No Relationships to Disclose
 
Hyunseon Kang
Travel, Accommodations, Expenses - Siemens Healthineers
 
Milind M. Javle
Honoraria - AstraZeneca/MedImmune; EMD Serono/Merck; Incyte; Merck; QED Therapeutics; TransThera Biosciences
Consulting or Advisory Role - AstraZeneca; Basilea Pharmaceutical; EMD Serono; incyte; Merck; Mundipharma; oncosil; QED Therapeutics
Other Relationship - Bayer; BeiGene; Incyte; Merck; Merck Serono; Novartis; Pieris Pharmaceuticals; QED Therapeutics; Rafael Pharmaceuticals; Seagen
 
Sunyoung S. Lee
No Relationships to Disclose